Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 950 participants.

Also called NCT03252626

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 950 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03252626
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03252626. Randomized; triple masking; primary purpose treatment. Start 2024-04-18 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
Condition
Stroke
Intervention (Drug)
Alprostadil
Intervention (Drug)
Normal saline
Lead sponsor
The First Hospital of Jilin University (class: other)

Record details

Record id
cardio:ct-nct03252626
Content hash
7ca1bf0896ead34d0040177e42738f852657db842e94e297db4219127e61839f